ENHANCEMENT OF THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PRETREATMENT WITH HEPARIN

被引:132
作者
CERCEK, B [1 ]
LEW, AS [1 ]
HOD, H [1 ]
YANO, J [1 ]
REDDY, NKN [1 ]
GANZ, W [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024
关键词
D O I
10.1161/01.CIR.74.3.583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:583 / 587
页数:5
相关论文
共 27 条
[21]  
MARCKWARDT F, 1977, HAEMOSTASIS, V6, P370
[22]  
MARSHALL ROBERT, 1963, THORAX, V18, P1, DOI 10.1136/thx.18.1.1
[23]   SULFITE PRECIPITATION METHOD FOR FIBRINOGEN MEASUREMENT - USE ON SMALL SAMPLES IN PRESENCE OF FIBRINOGEN DEGRADATION PRODUCTS [J].
RAMPLING, MW ;
GAFFNEY, PJ .
CLINICA CHIMICA ACTA, 1976, 67 (01) :43-52
[24]   RELATIONSHIP OF THE LYTIC STATE TO SUCCESSFUL REPERFUSION WITH STANDARD-DOSE AND LOW-DOSE INTRACORONARY STREPTOKINASE [J].
ROTHBARD, RL ;
FITZPATRICK, PG ;
FRANCIS, CW ;
CATON, DM ;
HOOD, WB ;
MARDER, VJ .
CIRCULATION, 1985, 71 (03) :562-570
[25]   CONTINUED INCORPORATION OF CIRCULATING RADIOLABELED FIBRINOGEN INTO PREFORMED CORONARY-ARTERY THROMBI [J].
SALIMI, A ;
OLIVER, GC ;
LEE, J ;
SHERMAN, LA .
CIRCULATION, 1977, 56 (02) :213-217
[26]   CORONARY THROMBOLYSIS WITH INTRAVENOUSLY ADMINISTERED HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR PRODUCED BY RECOMBINANT DNA TECHNOLOGY [J].
VANDEWERF, F ;
BERGMANN, SR ;
FOX, KAA ;
DEGEEST, H ;
HOYNG, CF ;
SOBEL, BE ;
COLLEN, D .
CIRCULATION, 1984, 69 (03) :605-610
[27]   SYSTEMIC MARKERS OF FIBRINOLYSIS AFTER UNSUCCESSFUL INTRACORONARY STREPTOKINASE THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - DOES NONREPERFUSION INDICATE FAILURE TO ACHIEVE A SYSTEMIC LYTIC STATE [J].
WHITE, CW ;
SCHWARTZ, JL ;
FERGUSON, DW ;
BRAYDEN, GP ;
KELLY, KJ ;
KIOSCHOS, JM ;
MARCUS, ML .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (07) :712-717